Live vaccine strain of Francisella tularensis: infection and immunity in mice - PubMed (original) (raw)

Live vaccine strain of Francisella tularensis: infection and immunity in mice

A H Fortier et al. Infect Immun. 1991 Sep.

Abstract

The live vaccine strain (LVS) of Francisella tularensis caused lethal disease in several mouse strains. Lethality depended upon the dose and route of inoculation. The lethal dose for 50% of the mice (LD50) in four of six mouse strains (A/J, BALB/cHSD, C3H/HeNHSD, and SWR/J) given an intraperitoneal (i.p.) inoculation was less than 10 CFU. For the other two strains tested, C3H/HeJ and C57BL/6J, the i.p. log LD50 was 1.5 and 2.7, respectively. Similar susceptibility was observed in mice inoculated by intravenous (i.v.) and intranasal (i.n.) routes: in all cases the LD50 was less than 1,000 CFU. Regardless of the inoculation route (i.p., i.v., or i.n.), bacteria were isolated from spleen, liver, and lungs within 3 days of introduction of bacteria; numbers of bacteria increased in these infected organs over 5 days. In contrast to the other routes of inoculation, mice injected with LVS intradermally (i.d.) survived infection: the LD50 of LVS by this route was much greater than 10(5) CFU. This difference in susceptibility was not due solely to local effects at the dermal site of inoculation, since bacteria were isolated from the spleen, liver, and lungs within 3 days by this route as well. The i.d.-infected mice were immune to an otherwise lethal i.p. challenge with as many as 10(4) CFU, and immunity could be transferred with either serum, whole spleen cells, or nonadherent spleen cells (but not Ig+ cells). A variety of infectious agents induce different disease syndromes depending on the route of entry. Francisella LVS infection in mice provides a model system for analysis of locally induced protective effector mechanisms.

PubMed Disclaimer

Similar articles

• T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
  Melillo AA, Foreman O, Bosio CM, Elkins KL. Melillo AA, et al. Infect Immun. 2014 Apr;82(4):1477-90. doi: 10.1128/IAI.01545-13. Epub 2014 Jan 13. Infect Immun. 2014. PMID: 24421047 Free PMC article.
• T-cell-independent resistance to infection and generation of immunity to Francisella tularensis.
  Elkins KL, Rhinehart-Jones T, Nacy CA, Winegar RK, Fortier AH. Elkins KL, et al. Infect Immun. 1993 Mar;61(3):823-9. doi: 10.1128/iai.61.3.823-829.1993. Infect Immun. 1993. PMID: 8432603 Free PMC article.
• Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.
  Elkins KL, Cowley SC, Bosio CM. Elkins KL, et al. Microbes Infect. 2003 Feb;5(2):135-42. doi: 10.1016/s1286-4579(02)00084-9. Microbes Infect. 2003. PMID: 12650771 Review.
• Nature of protective immunity to Francisella tularensis.
  Tärnvik A. Tärnvik A. Rev Infect Dis. 1989 May-Jun;11(3):440-51. Rev Infect Dis. 1989. PMID: 2665002 Review.

Cited by

• Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.
  Cuccui J, Thomas RM, Moule MG, D'Elia RV, Laws TR, Mills DC, Williamson D, Atkins TP, Prior JL, Wren BW. Cuccui J, et al. Open Biol. 2013 May 22;3(5):130002. doi: 10.1098/rsob.130002. Open Biol. 2013. PMID: 23697804 Free PMC article.
• Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages.
  Wilson JE, Katkere B, Drake JR. Wilson JE, et al. Infect Immun. 2009 Nov;77(11):4953-65. doi: 10.1128/IAI.00844-09. Epub 2009 Aug 24. Infect Immun. 2009. PMID: 19703975 Free PMC article.
• A multiplex polymerase chain reaction microarray assay to detect bioterror pathogens in blood.
  Tomioka K, Peredelchuk M, Zhu X, Arena R, Volokhov D, Selvapandiyan A, Stabler K, Mellquist-Riemenschneider J, Chizhikov V, Kaplan G, Nakhasi H, Duncan R. Tomioka K, et al. J Mol Diagn. 2005 Oct;7(4):486-94. doi: 10.1016/S1525-1578(10)60579-X. J Mol Diagn. 2005. PMID: 16237218 Free PMC article.
• Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis.
  Wickstrum JR, Hong KJ, Bokhari S, Reed N, McWilliams N, Horvat RT, Parmely MJ. Wickstrum JR, et al. Infect Immun. 2007 Mar;75(3):1335-42. doi: 10.1128/IAI.01203-06. Epub 2006 Dec 18. Infect Immun. 2007. PMID: 17178781 Free PMC article.
• Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
  Stevenson TC, Cywes-Bentley C, Moeller TD, Weyant KB, Putnam D, Chang YF, Jones BD, Pier GB, DeLisa MP. Stevenson TC, et al. Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):E3106-E3115. doi: 10.1073/pnas.1718341115. Epub 2018 Mar 19. Proc Natl Acad Sci U S A. 2018. PMID: 29555731 Free PMC article.

References

1. 1. Science. 1987 May 15;236(4803):834-7 - PubMed
2. 1. Infect Immun. 1975 Nov;12(5):999-1005 - PubMed
3. 1. J Immunol. 1965 Apr;94:578-85 - PubMed
4. 1. Bacteriol Rev. 1962 Sep;26:354-73 - PubMed
5. 1. J Immunol. 1961 Oct;87:415-25 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)